Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gudme Raaschou was a prominent Danish investment bank and asset management firm widely recognized for its specialized focus on the life sciences and healthcare sectors. The firm was particularly noted for managing the Gudme Raaschou Health Care fund, which invested globally in biotechnology, medical technology, and pharmaceutical companies. Following the financial crisis of 2008, the company underwent significant restructuring, leading to the acquisition of its asset management division by Maj Invest in 2010. Today, the legacy of its healthcare investment expertise continues under the Maj Invest brand, maintaining a strong presence in the Nordic biotech investment landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gudme Raaschou.